[ESPR] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
22-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -50.61%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 148,364 184,474 0 0 0 0 4,977,012 -44.30%
PBT -97,165 -201,810 -166,988 -74,978 -49,784 -36,375 -26,088 24.49%
Tax 11,857 2,875 2,132 1,672 1,060 229 1,131 47.91%
NP -109,022 -201,810 -166,988 -74,978 -49,784 -36,375 -26,088 26.90%
Tax Rate - - - - - - - -
Total Cost 257,386 386,284 166,988 74,978 49,784 36,375 5,003,100 -39.00%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -73.48 -109.40 0.00 0.00 0.00 0.00 -0.52 128.13%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -4.02 -7.54 -6.98 -3.33 -2.26 -2.22 -1.71 15.30%
EPS Diluted -4.02 -7.54 -6.98 -3.33 -2.26 -2.22 -1.70 15.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.